DK0618209T3 - Pyridothiadiaziner, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem - Google Patents

Pyridothiadiaziner, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem

Info

Publication number
DK0618209T3
DK0618209T3 DK94400627T DK94400627T DK0618209T3 DK 0618209 T3 DK0618209 T3 DK 0618209T3 DK 94400627 T DK94400627 T DK 94400627T DK 94400627 T DK94400627 T DK 94400627T DK 0618209 T3 DK0618209 T3 DK 0618209T3
Authority
DK
Denmark
Prior art keywords
pyridothiadiazines
processes
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
DK94400627T
Other languages
Danish (da)
English (en)
Inventor
Pierre Renard
Bernard Masereel
Bernard Pirotte
Jacques Delarge
Tullio Pascal De
Jean Lepagnol
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0618209T3 publication Critical patent/DK0618209T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK94400627T 1993-03-26 1994-03-24 Pyridothiadiaziner, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem DK0618209T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9303458A FR2703051B1 (fr) 1993-03-26 1993-03-26 Nouvelles pyridothiadiazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
DK0618209T3 true DK0618209T3 (da) 1999-08-23

Family

ID=9445338

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94400627T DK0618209T3 (da) 1993-03-26 1994-03-24 Pyridothiadiaziner, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem

Country Status (13)

Country Link
US (1) US5459138A (es)
EP (1) EP0618209B1 (es)
JP (1) JP2513989B2 (es)
AT (1) ATE174920T1 (es)
AU (1) AU673893B2 (es)
CA (1) CA2119853C (es)
DE (1) DE69415373T2 (es)
DK (1) DK0618209T3 (es)
ES (1) ES2128519T3 (es)
FR (1) FR2703051B1 (es)
GR (1) GR3029406T3 (es)
NZ (1) NZ260186A (es)
ZA (1) ZA942131B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5488056A (en) * 1994-10-31 1996-01-30 Eli Lilly And Company Method for treating anxiety
ATE248598T1 (de) * 1995-11-15 2003-09-15 Yamanouchi Pharma Co Ltd Inhibitoren der kainsäure-neurotoxizität sowie pyridothiazinderivate
US6225310B1 (en) 1996-01-17 2001-05-01 Novo Nordisk A/S Fused 1,2,4-thiadiazine derivatives, their preparation and use
KR19990077320A (ko) * 1996-01-17 1999-10-25 한센 핀 베네드, 안네 제헤르 피리도-1,2,4-티아디아진 및 피리도-1,4-티아진 유도체,그것의 제조방법 및 사용
WO1997026265A1 (en) * 1996-01-17 1997-07-24 Novo Nordisk A/S Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
WO1997039750A1 (en) * 1996-04-19 1997-10-30 The Regents Of The University Of California Treatment of mood/affective disorders by glutamatergic upmodulators
AR012020A1 (es) * 1996-09-24 2000-09-27 Dow Agrosciences Llc COMPUESTOS DE N - (TRIAZOLOAZINIL)ARILSULFONAMIDAS, COMPOSICIONES HERBICIDAS QUE LOS COMPRENDEN, MÉTODO PARA CONTROLAR VEGETACIoN INDESEABLE MEDIANTE SU APLICACIoN Y COMPUESTOS INTERMEDIARIOS uTILES COMO INTERMEDIARIOS EN SU PREPARACIoN.
US6329368B1 (en) * 1997-05-09 2001-12-11 The Regents Of The University Of California Endocrine modulation with positive modulators of AMPA type glutamate receptors
CN1264384A (zh) * 1997-07-16 2000-08-23 诺沃挪第克公司 稠合1,2,4-噻二嗪衍生物及其制备方法和用途
AU1663399A (en) * 1997-12-19 1999-07-12 Novo Nordisk A/S Pyrido 1,2,4-thiadiazine derivatives, their preparation and use
DE19824232A1 (de) * 1998-05-29 1999-12-02 Bayer Ag Pyridodithiazindioxide
DE19918021C1 (de) 1999-04-21 2000-06-29 Ruetgers Organics Gmbh Verfahren zur Herstellung von chlorierten Pyridinsulfonsäurechloriden
AU5521800A (en) * 1999-06-30 2001-01-22 Novo Nordisk A/S Novel process
IL151837A0 (en) 2000-03-20 2003-04-10 Teva Pharma Novel processes for preparing torsemide intermediate
WO2002000665A1 (en) * 2000-06-26 2002-01-03 Novo Nordisk A/S Use of potassium channel openers for the treatment of insulitis
AU2002307327A1 (en) * 2001-05-04 2002-11-18 Eli Lilly And Company Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes
US7902203B2 (en) 2002-11-01 2011-03-08 Abbott Laboratories, Inc. Anti-infective agents
US7378414B2 (en) 2003-08-25 2008-05-27 Abbott Laboratories Anti-infective agents
US7492956B2 (en) * 2004-08-18 2009-02-17 Cisco Technology, Inc. Video coding using multi-dimensional amplitude coding and 2-D non-zero/zero cluster position coding
DK1781265T3 (da) 2004-08-25 2010-08-02 Essentialis Inc Farmaceutiske formuleringer af kalium ATP-kanal-åbnere og anvendelser deraf
WO2006093801A1 (en) * 2005-02-25 2006-09-08 Abbott Laboratories Thiadiazine derivatives useful as anti-infective agents
EP1777219A1 (en) * 2005-10-20 2007-04-25 Faust Pharmaceuticals 1,2-Substituted naphthalene derivatives with antiglutamatergic properties and uses thereof
JP5543110B2 (ja) * 2006-01-05 2014-07-09 エッセンシャリス，インク． カリウムａｔｐチャネルオープナの塩およびその使用
CN100393726C (zh) * 2006-04-20 2008-06-11 山东大学 2,4-二取代杂环并[4,5-e][1,2,4]噻二嗪衍生物制备方法
CN110054647B (zh) * 2019-05-23 2021-06-15 上海勋和医药科技有限公司 托拉塞米磷酸酯类前药、其制备方法及组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3157647A (en) * 1960-10-31 1964-11-17 Olin Mathieson Process for producing nu-alkyl and nu-aralkyl thiadiazine compounds
US3288678A (en) * 1963-09-12 1966-11-29 Ciba Geigy Corp Diuretic compositions
GB1368948A (en) * 1970-11-11 1974-10-02 Manuf Prod Pharma Pyridine derivatives
JPS5854158B2 (ja) * 1975-10-02 1983-12-02 ヒサミツセイヤク カブシキガイシヤ シンキナピリドチアジアジンユウドウタイノセイゾウホウ

Also Published As

Publication number Publication date
AU5904894A (en) 1994-09-29
JPH072872A (ja) 1995-01-06
DE69415373T2 (de) 1999-08-26
CA2119853C (fr) 2002-09-10
JP2513989B2 (ja) 1996-07-10
CA2119853A1 (fr) 1994-09-27
DE69415373D1 (de) 1999-02-04
NZ260186A (en) 1995-07-26
EP0618209B1 (fr) 1998-12-23
AU673893B2 (en) 1996-11-28
FR2703051A1 (fr) 1994-09-30
EP0618209A1 (fr) 1994-10-05
ES2128519T3 (es) 1999-05-16
GR3029406T3 (en) 1999-05-28
ZA942131B (en) 1995-04-05
FR2703051B1 (fr) 1995-04-28
US5459138A (en) 1995-10-17
ATE174920T1 (de) 1999-01-15

Similar Documents

Publication Publication Date Title
DK0618209T3 (da) Pyridothiadiaziner, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0513543T3 (da) Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og antikoagulationsmidler med indehold deraf
DK0580502T3 (da) 3-(hydroxybenzylidenyl)-indolin-2-oner og farmaceutiske sammensætninger indeholdende disse
DK0659747T3 (da) Forgrenede aminothiazolderivater, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem
DK0486386T3 (da) Hidtil ukendte N-benzoylprolinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0632026T3 (da) Alfa-aminosyrederivater, en fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger, der indeholder dem
DK0564358T3 (da) 3-aminochroman-spiro-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne
AU6187394A (en) New pyrrolopyrazine compounds, processes for their preparation and the pharmaceutical compositions which contain them
CY2160B1 (en) Erburnane derivatives processes for their preparation and pharmaceutical compositions containing them
DK0612763T3 (da) Cykliske angiopeptinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0410278T3 (da) Reninhæmmende aminooligohydroxyderivater
DK0635491T3 (da) (Thia)cycloalkylab indoler, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse forbindelser.
DK0611755T3 (da) Hidtil ukendte (cyklohexyl)alkenforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem